Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BCYC will decline by -6.23% over the next 2 Weeks and hit $3.71 by Wednesday, July 8, 2026. In that time frame, BCYC's share price is expected to range between $3.56 and $3.87.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Jul 8, 2026 | 3.56 | 3.71 | 3.87 |
| Jul 7, 2026 | 3.53 | 3.70 | 3.87 |
| Jul 6, 2026 | 3.57 | 3.74 | 3.91 |
| Jul 3, 2026 | 3.62 | 3.79 | 3.95 |
| Jul 2, 2026 | 3.68 | 3.84 | 4.00 |
| Jul 1, 2026 | 3.69 | 3.85 | 4.01 |
| Jun 30, 2026 | 3.67 | 3.84 | 4.00 |
| Jun 29, 2026 | 3.71 | 3.88 | 4.02 |
| Jun 26, 2026 | 3.76 | 3.93 | 4.10 |
| Jun 25, 2026 | 3.81 | 3.98 | 4.13 |
BCYC shares rose +1.26% in Thursday, June 25, 2026's trading session, rising from a previous close of $3.96 to move at $4.01. The stock demonstrated notable intraday movement (see BCYC's key stats for a full breakdown), fluctuating between $3.94 and $4.04, a +2.54% trading range. While recent weeks have seen some volatility, BCYC has managed to secure a -2.20% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 504.34K shares changing hands, 102.58K more than the previous session. This amounted to $2.02M in total market activity.
Will BCYC Continue Its Downward Trend?
According to analyst ratings and projections for BCYC, Bicycle Therapeutics plc shares are anticipated to decrease by -3.63%, potentially reaching $3.87 per share by July 8, 2026. Short-term technical indicators currently suggest a neutral sentiment for BCYC. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the BCYC stock forecast, now is not the best time to buy BCYC stock because its current trading price is +7.99% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on BCYC covering social and institutional perspectives.
BCYC Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BCYC's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 37.71% to 38.49%) suggest the stock is in a weak bearish momentum phase. The 50-day RSI, at 41.52%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 43.26%, maintains a neutral outlook for the long term. Insights into BCYC's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Bicycle Therapeutics Short-Term Forecasts
BCYC Forecast For Next 5 Days
Our algorithm anticipates Bicycle Therapeutics (BCYC) stock could hit $4.24 by Jul 02, 2026. This represents a +5.65% rise from today's price, following a +1.37% change over the past five days.
BCYC Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Bicycle Therapeutics plc (BCYC) stock over the next 30 days is largely negative. Price forecasts suggest an average target of $3.95, which would mean a -1.50% decrease from the current price of $4.01. Projections for this period range from a high of $4.58 to a low of $3.12.
BCYC Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Bicycle Therapeutics's price over the next three months point to a rise. BCYC stock is expected to peak at $7.62 on Jul 21, 2026 before potentially dipping to $5.91 on Sep 18, 2026. On average, BCYC is likely to trade around $6.86 in the coming 90 days.
Bicycle Therapeutics Stock Forecast 2025
Based on our predictive models, Bicycle Therapeutics (BCYC) is expected to trade between $1.41 and $8.17 throughout 2026. This would result in an average price of $6.75, potentially offering investors a +68.33% return from current levels.
Bicycle Therapeutics plc Monthly Forecast 2026–2027
June 2026
According to our latest forecast models, Bicycle Therapeutics plc (BCYC) is positioned to show a strong performance in June 2026. The price is predicted to move between $6.28 and $6.96, settling at an average of $6.63. This could translate to a +65.34% gain.
July 2026
Based on current market signals, Bicycle Therapeutics plc is projected to trend july 2026. We forecast a trading range from $6.29 to $7.62, with a likely average price of $6.96. Investors could expect a potential return of +73.57%.
August 2026
Our predictive algorithms indicate Bicycle Therapeutics plc stock may see a shift in August 2026. The expected range spans $6.00–$7.32, with an average target of $6.71. This represents a positive outlook and a possible gain of +67.33%.
September 2026
Analyzing established trends, Bicycle Therapeutics plc looks set to move in September 2026. Projections place the stock between $5.91 and $8.00, averaging around $7.03. This suggests a +75.31% gain from current levels.
October 2026
Market indicators suggest Bicycle Therapeutics plc could experience notable changes during October 2026. Prices could fluctuate within $5.14 to $8.17, with a midpoint forecast of $7.57. The stock might deliver a +88.78% gain.
November 2026
Forecasting for November 2026, models estimate that Bicycle Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $3.09 and $7.08, averaging $6.41. This signals a positive trajectory with potential returns around +59.85%.
December 2026
According to our latest forecast models, Bicycle Therapeutics plc (BCYC) is positioned to show a strong performance in December 2026. The price is predicted to move between $1.41 and $5.83, settling at an average of $5.82. This could translate to a +45.14% gain.
January 2027
Based on current market signals, Bicycle Therapeutics plc is projected to trend january 2027. We forecast a trading range from $0.00 to $4.61, with a likely average price of $5.34. Investors could expect a potential return of +33.17%.
February 2027
Our predictive algorithms indicate Bicycle Therapeutics plc stock may see a shift in February 2027. The expected range spans $0.00–$3.86, with an average target of $5.17. This represents a positive outlook and a possible gain of +28.93%.
March 2027
Analyzing established trends, Bicycle Therapeutics plc looks set to move in March 2027. Projections place the stock between $0.00 and $3.87, averaging around $5.04. This suggests a +25.69% gain from current levels.
April 2027
Market indicators suggest Bicycle Therapeutics plc could experience notable changes during April 2027. Prices could fluctuate within $0.00 to $2.40, with a midpoint forecast of $3.79. The stock might deliver a -5.49% loss.
May 2027
Forecasting for May 2027, models estimate that Bicycle Therapeutics plc may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.60, averaging $3.75. This signals a cautious trajectory with potential returns around -6.48%.
June 2027
According to our latest forecast models, Bicycle Therapeutics plc (BCYC) is positioned to show a strong performance in June 2027. The price is predicted to move between $0.00 and $1.40, settling at an average of $3.83. This could translate to a -4.49% loss.
BCYC's history of dividends and stock splits also plays a role in long-term investor confidence.